lisocabtagene maraleucel Breyanzi
Selected indexed studies
- Clinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy. (Curr Oncol, 2025) [PMID:40862794]
- Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. (Cancers (Basel), 2023) [PMID:37297020]
- Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy. (Int J Mol Sci, 2025) [PMID:41155207]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Clinical Impact of CTLA-4 Single-Nucleotide Polymorphism in DLBCL Patients Treated with CAR-T Cell Therapy. (2025) pubmed
- Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. (2023) pubmed
- Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy. (2025) pubmed